The effect of Niagara® Cycloid® action on legs with chronic oedema/lymphoedema following treatment for cancer in patients aged 45 to 75.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2024
This article has no abstract
Epistemonikos ID: e8dc549dd63239f7b18974c3dbd9b5bc1988dac4
First added on: Mar 18, 2025